Morgan Stanley
HITK

Morgan Stanley’s HI-TECH PHARMACAL INC HITK Stock Holding History

Morgan Stanley’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-429,895
Closed -$18.6M – 6807
2014
Q1 		$18.6M Buy
429,895
+27,899
+7% +$1.21M 0.01% 1430
2013
Q4 		$17.4M Buy
401,996
+41,378
+11% +$1.79M 0.01% 1464
2013
Q3 		$15.6M Buy
360,618
+338,607
+1,538% +$13M 0.01% 1429
2013
Q2 		$731K Buy
+22,011
New +$733K ﹤0.01% 3981

Morgan Stanley's HITK Position: Q2 2014 in Review

Morgan Stanley sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 429,895 shares — an estimated $18.6M sold.

Morgan Stanley first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $18.6M in Q1 2014. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

  • Morgan Stanley reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
  • Morgan Stanley sold 429,895 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $18.6M.
  • Morgan Stanley first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
  • Morgan Stanley's HI-TECH PHARMACAL INC position peaked at $18.6M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Morgan Stanley's 13F filing for Q2 2014, filed 12 Aug 2014.